Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Neil

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Cancer Research|April 1, 1973
Cell-kill kinetics of several S-phase-specific drugsB K Bhuyan, T J Fraser, L G Gray, et al.
Cancer Research|December 1, 1971
Biological and biochemical differences between tubercidin (7-deazaadenosine) and its 5'-phosphate methyl esterB K Bhuyan, G L Neil, C G Smith, et al.
Cancer Research|June 1, 1977
Antitumor activity and preliminary drug disposition studies on chartreusin (NSC 5159)J P McGovren, G L Neil, S L Crampton, et al.
Advances in Enzyme Regulation|January 1, 1978
Studies of the biochemical pharmacology of the fermentation-derived antitumor agent, (alpha S, 5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125)G L Neil, A E Berger, B K Bhuyan, et al.
Antibiotics and Chemotherapy|January 1, 1978
A multi-end point in vitro system for detection of new antitumor drugsL J Hanka, B K Bhuyan, D G Martin, et al.
Cancer Research|September 1, 1977
Partial synchronization of L1210 cells by 5-fluorouracil and its use in drug combinationsB K Bhuyan, C L Blowers, G L Neil, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1978
Detection and assay of antitumor antibioticsL J Hanka, S L Kuentzel, D G Martin, et al.
The Journal of Antibiotics|April 1, 1984
Biological evaluation of stability of 5-azacytidineL H Li, H H Buskirk, C L Blowers, et al.
Cancer Chemotherapy Reports|March 1, 1974
Tissue distribution of streptozotocin (NSC-85998)B K Bhuyan, S L Kuentzel, L G Gray, et al.
Biochemical Pharmacology|December 1, 1971
Biochemical and pharmacologic studies with 1- -D-arabinofuranosylcytosine 5'-adamantoate (NSC-117614), a depot form of cytarabineG L Neil, H H Buskirk, T E Moxley, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Cancer Research|April 1, 1973
Cell-kill kinetics of several S-phase-specific drugsB K Bhuyan, T J Fraser, L G Gray, et al.
Cancer Research|December 1, 1971
Biological and biochemical differences between tubercidin (7-deazaadenosine) and its 5'-phosphate methyl esterB K Bhuyan, G L Neil, C G Smith, et al.
Cancer Research|June 1, 1977
Antitumor activity and preliminary drug disposition studies on chartreusin (NSC 5159)J P McGovren, G L Neil, S L Crampton, et al.
Advances in Enzyme Regulation|January 1, 1978
Studies of the biochemical pharmacology of the fermentation-derived antitumor agent, (alpha S, 5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125)G L Neil, A E Berger, B K Bhuyan, et al.
Antibiotics and Chemotherapy|January 1, 1978
A multi-end point in vitro system for detection of new antitumor drugsL J Hanka, B K Bhuyan, D G Martin, et al.
Cancer Research|September 1, 1977
Partial synchronization of L1210 cells by 5-fluorouracil and its use in drug combinationsB K Bhuyan, C L Blowers, G L Neil, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1978
Detection and assay of antitumor antibioticsL J Hanka, S L Kuentzel, D G Martin, et al.
The Journal of Antibiotics|April 1, 1984
Biological evaluation of stability of 5-azacytidineL H Li, H H Buskirk, C L Blowers, et al.
Cancer Chemotherapy Reports|March 1, 1974
Tissue distribution of streptozotocin (NSC-85998)B K Bhuyan, S L Kuentzel, L G Gray, et al.
Biochemical Pharmacology|December 1, 1971
Biochemical and pharmacologic studies with 1- -D-arabinofuranosylcytosine 5'-adamantoate (NSC-117614), a depot form of cytarabineG L Neil, H H Buskirk, T E Moxley, et al.
Pageof 5